Logo image of GSRT

GSR III ACQUISITION CORP (GSRT) Stock Fundamental Analysis

USA - NASDAQ:GSRT - KYG4R1031072 - Common Stock

10.27 USD
-0.01 (-0.1%)
Last: 10/3/2025, 8:00:01 PM
10.1667 USD
-0.1 (-1.01%)
After Hours: 10/3/2025, 8:00:01 PM
Fundamental Rating

2

GSRT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. GSRT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GSRT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GSRT was profitable.
GSRT had a negative operating cash flow in the past year.
GSRT Yearly Net Income VS EBIT VS OCF VS FCFGSRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 500K -500K

1.2 Ratios

Industry RankSector Rank
ROA 1.71%
ROE 1.78%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSRT Yearly ROA, ROE, ROICGSRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -50 -100 -150

1.3 Margins

GSRT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GSRT Yearly Profit, Operating, Gross MarginsGSRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

GSRT has more shares outstanding than it did 1 year ago.
GSRT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GSRT Yearly Shares OutstandingGSRT Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M 20M 25M
GSRT Yearly Total Debt VS Total AssetsGSRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M 200M

2.2 Solvency

GSRT has an Altman-Z score of 20.93. This indicates that GSRT is financially healthy and has little risk of bankruptcy at the moment.
GSRT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 20.93
ROIC/WACCN/A
WACCN/A
GSRT Yearly LT Debt VS Equity VS FCFGSRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.10 indicates that GSRT should not have too much problems paying its short term obligations.
A Quick Ratio of 1.10 indicates that GSRT should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
GSRT Yearly Current Assets VS Current LiabilitesGSRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 6850.00% over the past year.
EPS 1Y (TTM)6850%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5533.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

GSRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -84.51% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-276.3%
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSRT Yearly EPS VS EstimatesGSRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GSRT is valuated quite expensively with a Price/Earnings ratio of 68.47.
When comparing the Price/Earnings ratio of GSRT to the average of the S&P500 Index (27.86), we can say GSRT is valued expensively.
GSRT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 68.47
Fwd PE N/A
GSRT Price Earnings VS Forward Price EarningsGSRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSRT Per share dataGSRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as GSRT's earnings are expected to decrease with -84.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%

More info and screens

0

5. Dividend

5.1 Amount

GSRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GSR III ACQUISITION CORP

NASDAQ:GSRT (10/3/2025, 8:00:01 PM)

After market: 10.1667 -0.1 (-1.01%)

10.27

-0.01 (-0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11 2025-08-11
Earnings (Next)12-15 2025-12-15
Inst Owners58.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap352.67M
Analysts82.5
Price Target19.89 (93.67%)
Short Float %1.61%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.63%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 68.47
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.55
P/tB 1.55
EV/EBITDA N/A
EPS(TTM)0.15
EY1.46%
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS6.62
TBVpS6.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.71%
ROE 1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 20.93
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6850%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5533.33%
EPS Next Y-276.3%
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2704.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1004.19%
EBIT Next 3Y-253.25%
EBIT Next 5YN/A
FCF growth 1Y-2114.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2114.4%
OCF growth 3YN/A
OCF growth 5YN/A